Journal Article

The endothelin–parathyroid hormone-related protein vasoactive peptide system in human endometrium: modulation by transforming growth factor-β

M. Linette Casey and Paul C. MacDonald

in Human Reproduction

Published on behalf of European Society of Human Reproduction and Embryology

Volume 11, issue suppl_2, pages 62-82
Published in print October 1996 | ISSN: 0268-1161
e-ISSN: 1460-2350 | DOI: http://dx.doi.org/10.1093/humrep/11.suppl_2.62
The endothelin–parathyroid hormone-related protein vasoactive peptide system in human endometrium: modulation by transforming growth factor-β

Show Summary Details

Preview

Endothelin-1 (ET-1), a potent vasoconstrictor, and parathyroid hormone-related protein (PTH-rP), a potent vasorelaxant, are present and synthesized in human endometrium. The production of these vasoactive peptides in stromal cells of the human endometrium is modulated by sex steroid hormones. In addition, neutral endopeptidase 24.11 (also called enkephalinase), which degrades ET-1, is expressed in the stromal cells of the endometrium, and the levels of this enzyme (mRNA, protein and specific activity) are increased in response to progesterone/progestin. The sex steroid hormone-mediated regulation of vasoactive peptide formation and action in the human endometrium is believed to serve a key role in modulating spiral artery tone/blood flow, and thus endometrial bleeding, whether progestin induced or naturally occurring. Moreover, the expression of ET-1, PTH-rP and enkephalinase is modulated by transforming growth factor-β. We hypothesize that the inappropriate expression of ET-1, enkephalinase and PTH-rP in endometrial stromal cells during synthetic progestin administration may be one cause of abnormal endometrial development and erratic endometrial bleeding.

Keywords: endothelin-1; enkephalinase; parathyroid hormone related protein; progestin; transforming growth factor-β

Journal Article.  0 words. 

Subjects: Reproductive Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.